Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity.
about
Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytomaPhase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.Meningiomas: a comparative study of 68Ga-DOTATOC, 68Ga-DOTANOC and 68Ga-DOTATATE for molecular imaging in mice.Dose-painting intensity-modulated proton therapy for intermediate- and high-risk meningiomaCXCR4 and SDF1 expression in human meningiomas: a proliferative role in tumoral meningothelial cells in vitroCombination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma.Expression of somatostatin receptors (SSTR1-SSTR5) in meningiomas and its clinicopathological significance.Peptide receptor targeting in cancer: the somatostatin paradigm.68Gallium-DOTATATE PET in meningioma: A reliable predictor of tumor growth rate?Different response of human glioma tumor-initiating cells to epidermal growth factor receptor kinase inhibitors.Treatment recommendations for primary extradural meningiomas.Angiogenesis in meningiomas.Medical treatment of recurrent meningiomas.Chemotherapy: What is its role in meningioma?Medical management of meningiomas.CXC receptor and chemokine expression in human meningioma: SDF1/CXCR4 signaling activates ERK1/2 and stimulates meningioma cell proliferation.Imatinib mesylate treatment of recurrent meningiomas in preselected patients: a retrospective analysis.Pasireotide is more effective than octreotide, alone or combined with everolimus on human meningioma in vitroSomatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE/-TOC uptakeSomatostatin receptor 2a is a more sensitive diagnostic marker of meningioma than epithelial membrane antigen.Pulmonary metastases in patients with recurrent, treatment-resistant meningioma: prognosis and identification by ¹¹¹Indium-octreotide imaging.Differential efficacy of SSTR1, -2, and -5 agonists in the inhibition of C6 glioma growth in nude mice.Systemic therapy for recurrent meningioma.Correlation between 99mTc-HYNIC-octreotide SPECT/CT somatostatin receptor scintigraphy and pathological grading of meningioma.Dual use of E-cadherin and D2-40 immunostaining in unusual meningioma subtypes.Value of SSTR2A and Claudin - 1 in Differentiating Meningioma from Schwannoma and Hemangiopericytoma.Emerging Medical Treatments for Meningioma in the Molecular EraPET and PET/CT with 68gallium-labeled somatostatin analogues in Non GEP-NETs Tumors
P2860
Q34977393-C3E598C9-A20C-433F-B50B-F49B9E366A31Q35106253-65F75D8F-B3AC-4633-8212-FE82AF9E6F16Q35392459-F6285E49-9C5E-447F-9B2E-55EE3512E05FQ35504767-0FA4E761-C7A6-4499-9A43-ABF3B4525C13Q35688332-2165B68E-FA56-494E-9C34-31F5ECF1AC9EQ36226361-FDDDDF27-CE08-4B38-9DAF-85B821538E6FQ36375359-2CC8E255-611B-469B-8613-24F98AFBAEB5Q36638046-CFC4319B-F3FD-46F6-AB24-4A16B6EF04A0Q36977694-6C363B2A-C172-4113-97C7-FDB04222C0D3Q37119850-7EE39804-D5CE-404D-BA65-C4DB3C5DF585Q37786296-8CAEA778-A5CE-4B8F-B79E-B4389F9F1530Q37835102-EBD34452-BDE1-4DF5-9AF1-C2798E923465Q37939997-E29594EE-7580-4795-8141-E3AAE162F0F8Q38053441-32C7A86A-3A5A-4BCC-8163-593C7DB9AC8EQ38233448-95F2CB42-755F-40FE-8DB4-CB213BD70CCAQ38303390-7B707D33-EB8B-469E-8786-5E350956C7C6Q39615481-6C51D82F-D6E0-4A42-B5B8-98FFFAB54375Q41548629-7A683E4E-F01A-4D4E-95C6-B82A2B4CE45CQ42702315-6ADD7FFB-42E1-478F-91C6-6C94E872CCD7Q46524700-7C66FE8F-9362-45B0-837A-53FC0CF38028Q46614069-5A407DB3-B773-4632-98B5-015FF2386B92Q48476082-A29B85FD-195E-47A1-B7A3-EA31F729AE33Q48787594-FBA78A0C-FA7F-4D17-9D5D-B81F7EA2AD57Q51009564-EB7D6393-75EA-433C-8688-02215429CC46Q52146814-02A9B880-1D31-4E96-9F8C-FA5D693F4017Q53838103-35F83442-E2BD-40B0-B502-AA55942C92F2Q58798211-7E3BA896-4B52-4430-8525-C9ABF6D84A12Q59074896-72E4EF83-C7DE-4DA5-95A5-2102B5A9488B
P2860
Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Expression of somatostatin rec ...... ro antiproliferative activity.
@en
Expression of somatostatin rec ...... ro antiproliferative activity.
@nl
type
label
Expression of somatostatin rec ...... ro antiproliferative activity.
@en
Expression of somatostatin rec ...... ro antiproliferative activity.
@nl
prefLabel
Expression of somatostatin rec ...... ro antiproliferative activity.
@en
Expression of somatostatin rec ...... ro antiproliferative activity.
@nl
P2093
P50
P1476
Expression of somatostatin rec ...... tro antiproliferative activity
@en
P2093
Alessandra Dorcaratto
Gabriella Lapertosa
Gennaro Schettini
Jean-Louis Ravetti
Paolo Pirani
Patrizia Dadati
Renato Spaziante
Sara Arena
Valentina Villa
P304
P356
10.1023/B:NEON.0000013498.19981.55
P577
2004-01-01T00:00:00Z
P5875
P6179
1043919874